Royalty Pharma plc
RPRX stock score: 60/100
$63.75 · +2.57% · Scored Oct 22, 2026
- Technical
- 72
- Fundamental
- 48
- News
- 51
The reading
Royalty Pharma (RPRX) scores 60 out of 100, which reads neutral, higher than 86% of Healthcare stocks and 74% of the 4,161 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 72, fundamentals 48.
Among the fundamentals, Fund Ownership at 100 and Revenue Quality (Quarterly) at 100 score highest, while Earnings Growth (5-Year) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 71 and contrarian oscillators 26 — a split worth reading before trusting the technical total.
News sentiment is neutral at 51; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 55 to 74, and it is down 12 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward RPRX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
48Pulling it up
- Fund Ownership100
Fund ownership tracks institutional investor holdings and changes.
- Revenue Quality (Quarterly)100
Revenue Quality (Quarterly) evaluates recent revenue performance using trailing 12-month data from quarterly reports.
- EBITDA Margins99
EBITDA margins measure operating profitability before interest, taxes, depreciation, and amortization.
Holding it back
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
- Earnings Growth (Quarterly)2
Quarterly earnings growth measures profit increase versus the prior-year quarter.
- Price to Sales Ratio3
Price-to-Sales ratio compares market capitalization to annual revenue.
40 weighted scorers; 1 had no data today and are left out rather than counted as zero.
Technical · daily
67Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- VWAP100
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
- Ichimoku Cloud100
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
Holding it back
- Bollinger Bands (20)0
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- Williams %R (28)0
Williams %R (28-period) places the close within the last 28 periods' high-low range.
- Williams %R (14)0
Williams %R (14-period) measures where the current price sits within the recent high-low range.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 51
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 59 | 1 |
| Daily | 67 | 3 |
| Weekly | 71 | 2 |
| Monthly | 77 | 2 |
| Quarterly | 80 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 60 |
| Oct 21, 2026 | 60 |
| Oct 20, 2026 | 60 |
| Oct 19, 2026 | 59 |
| Oct 18, 2026 | 60 |
| Oct 17, 2026 | 60 |
| Oct 16, 2026 | 60 |
| Oct 15, 2026 | 60 |
| Oct 14, 2026 | 59 |
| Oct 13, 2026 | 56 |
| Oct 12, 2026 | 58 |
| Oct 11, 2026 | 56 |
| Oct 10, 2026 | 56 |
| Oct 9, 2026 | 56 |
| Oct 8, 2026 | 56 |
| Oct 7, 2026 | 56 |
| Oct 6, 2026 | 55 |
| Oct 5, 2026 | 55 |
| Oct 4, 2026 | 55 |
| Oct 3, 2026 | 55 |
| Oct 2, 2026 | 56 |
| Oct 1, 2026 | 55 |
| Sep 30, 2026 | 58 |
| Sep 29, 2026 | 57 |
| Sep 28, 2026 | 57 |
| Sep 27, 2026 | 57 |
| Sep 26, 2026 | 57 |
| Sep 25, 2026 | 57 |
| Sep 24, 2026 | 58 |
| Sep 23, 2026 | 59 |
| Sep 22, 2026 | 57 |
| Sep 21, 2026 | 57 |
| Sep 20, 2026 | 57 |
| Sep 19, 2026 | 57 |
| Sep 18, 2026 | 57 |
| Sep 17, 2026 | 56 |
| Sep 16, 2026 | 57 |
| Sep 15, 2026 | 57 |
| Sep 14, 2026 | 58 |
| Sep 13, 2026 | 57 |
| Sep 12, 2026 | 57 |
| Sep 11, 2026 | 57 |
| Sep 10, 2026 | 57 |
| Sep 9, 2026 | 59 |
| Sep 8, 2026 | 59 |
| Sep 7, 2026 | 59 |
| Sep 6, 2026 | 59 |
| Sep 5, 2026 | 59 |
| Sep 4, 2026 | 59 |
| Sep 3, 2026 | 61 |
| Sep 2, 2026 | 61 |
| Sep 1, 2026 | 61 |
| Aug 31, 2026 | 60 |
| Aug 30, 2026 | 59 |
| Aug 29, 2026 | 59 |
| Aug 28, 2026 | 59 |
| Aug 27, 2026 | 60 |
| Aug 26, 2026 | 59 |
| Aug 25, 2026 | 60 |
| Aug 24, 2026 | 60 |
| Aug 23, 2026 | 60 |
| Aug 22, 2026 | 60 |
| Aug 20, 2026 | 63 |
| Aug 19, 2026 | 63 |
| Aug 18, 2026 | 62 |
| Aug 17, 2026 | 62 |
| Aug 16, 2026 | 61 |
| Aug 15, 2026 | 61 |
| Aug 14, 2026 | 60 |
| Aug 13, 2026 | 61 |
| Aug 12, 2026 | 63 |
| Aug 11, 2026 | 61 |
| Aug 10, 2026 | 60 |
| Aug 9, 2026 | 59 |
| Aug 8, 2026 | 59 |
| Aug 7, 2026 | 60 |
| Aug 6, 2026 | 57 |
| Aug 5, 2026 | 57 |
| Aug 3, 2026 | 56 |
| Aug 2, 2026 | 56 |
| Jul 31, 2026 | 74 |
| Jul 30, 2026 | 72 |
| Jul 29, 2026 | 71 |
| Jul 28, 2026 | 72 |
| Jul 27, 2026 | 72 |
| Jul 26, 2026 | 72 |
| Jul 25, 2026 | 72 |
Key facts
- Market cap
- $36.8B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 0.41
- Risk grade (1–10)
- 5
- Next earnings
- Nov 4, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| ARGX argenx SE | $55.1B | 64 |
| ONC BeOne Medicines AG | $43.5B | 66 |
| RVMD Revolution Medicines | $40.2B | 43 |
| ALNY Alnylam Pharmaceuticals | $30.4B | 54 |
| ROIV Roivant Sciences | $27.1B | 48 |
| GMAB Genmab A/S | $24.6B | 67 |
Questions
What is RPRX's stock score today?
RPRX scores 60/100 (Neutral) as of Oct 22, 2026: technical 72, fundamental 48, and news sentiment 51, which is shown but not counted. Scores are recomputed every night.
Is RPRX a buy?
The score is not a buy or sell recommendation. A 60 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the RPRX score calculated?
102 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.